The analysis of minimal residual disease (MRD) has assumed a growing role in the follow-up of patients with acute lymphoblastic leukemia (ALL). We have applied multiparameter flow cytometry (FC) with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback